SCOPUS 정보 검색 플랫폼

Volumn 63, Issue 1, 2013, Pages 42-46

Dopamine D2 receptor-mediated modulation of adenosine A 2A receptor agonist binding within the A2AR/D2R oligomer framework

(9) Fernández Dueñas, Víctor a Gómez Soler, Maricel a Morató, Xavier a Núñez, Fabiana a Das, Arijit b Kumar, T Santhosh b Jaumà, Serge c Jacobson, Kenneth A b Ciruela, Francisco a

a Unitat de Bioquimica (Spain)

b NATIONAL INSTITUTES OF HEALTH (United States)

c CS Principes Espana (Spain)

Author keywords

A2AR; Antiparkinsonian drugs; D2R; Parkinson's disease; Receptor receptor allosterism

Indexed keywords

ADENOSINE A2 RECEPTOR AGONIST; APOMORPHINE; DOPAMINE 2 RECEPTOR; OLIGOMER; PRAMIPEXOLE; ROTIGOTINE;

ALLOSTERISM; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OLIGOMERIZATION; PRIORITY JOURNAL;

ADENOSINE A2 RECEPTOR AGONISTS; BIOPOLYMERS; FLOW CYTOMETRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELLS; HUMANS; PROTEIN BINDING; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D2;

EID: 84878860108 PISSN: 01970186 EISSN: 18729754 Source Type: Journal
DOI: 10.1016/j.neuint.2013.04.006 Document Type: Article

Times cited : (21)

References (13)

1
- 4544278502
- Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors
- F. Ciruela, J. Burgueno, V. Casado, M. Canals, D. Marcellino, S.R. Goldberg, M. Bader, K. Fuxe, L.F. Agnati, C. Lluis, R. Franco, S. Ferre, and A.S. Woods Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors Anal. Chem. 76 2004 5354 5363
- (2004) Anal. Chem. , vol.76 , pp. 5354-5363
- Ciruela, F.¹ Burgueno, J.² Casado, V.³ Canals, M.⁴ Marcellino, D.⁵ Goldberg, S.R.⁶ Bader, M.⁷ Fuxe, K.⁸ Agnati, L.F.⁹ Lluis, C.¹⁰ Franco, R.¹¹ Ferre, S.¹² Woods, A.S.¹³

2
- 33644551294
- Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers
- F. Ciruela, V. Casado, R.J. Rodrigues, R. Lujan, J. Burgueno, M. Canals, J. Borycz, N. Rebola, S.R. Goldberg, J. Mallol, A. Cortes, E.I. Canela, J.F. Lopez-Gimenez, G. Milligan, C. Lluis, R.A. Cunha, S. Ferre, and R. Franco Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers J. Neurosci. 26 2006 2080 2087
- (2006) J. Neurosci. , vol.26 , pp. 2080-2087
- Ciruela, F.¹ Casado, V.² Rodrigues, R.J.³ Lujan, R.⁴ Burgueno, J.⁵ Canals, M.⁶ Borycz, J.⁷ Rebola, N.⁸ Goldberg, S.R.⁹ Mallol, J.¹⁰ Cortes, A.¹¹ Canela, E.I.¹² Lopez-Gimenez, J.F.¹³ Milligan, G.¹⁴ Lluis, C.¹⁵ Cunha, R.A.¹⁶ Ferre, S.¹⁷ Franco, R.¹⁸

3
- 84867331019
- Molecular determinants of A(2A) R-D(2) R allosterism: Role of the intracellular loop 3 of the D(2) R
- V. Fernandez-Duenas, M. Gomez-Soler, K.A. Jacobson, S.T. Kumar, K. Fuxe, D.O. Borroto-Escuela, and F. Ciruela Molecular determinants of A(2A) R-D(2) R allosterism: role of the intracellular loop 3 of the D(2) R J. Neurochem. 123 2012 373 384
- (2012) J. Neurochem. , vol.123 , pp. 373-384
- Fernandez-Duenas, V.¹ Gomez-Soler, M.² Jacobson, K.A.³ Kumar, S.T.⁴ Fuxe, K.⁵ Borroto-Escuela, D.O.⁶ Ciruela, F.⁷

4
- 2942552330
- Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders
- S. Ferre, F. Ciruela, M. Canals, D. Marcellino, J. Burgueno, V. Casado, J. Hillion, M. Torvinen, F. Fanelli, Pd.P. Benedetti, S.R. Goldberg, M. Bouvier, K. Fuxe, L.F. Agnati, C. Lluis, R. Franco, and A. Woods Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders Parkinsonism Relat. Disord. 10 2004 265 271
- (2004) Parkinsonism Relat. Disord. , vol.10 , pp. 265-271
- Ferre, S.¹ Ciruela, F.² Canals, M.³ Marcellino, D.⁴ Burgueno, J.⁵ Casado, V.⁶ Hillion, J.⁷ Torvinen, M.⁸ Fanelli, F.⁹ Benedetti, Pd.P.¹⁰ Goldberg, S.R.¹¹ Bouvier, M.¹² Fuxe, K.¹³ Agnati, L.F.¹⁴ Lluis, C.¹⁵ Franco, R.¹⁶ Woods, A.¹⁷

5
- 47349126631
- An update on adenosine A2A-dopamine D2 receptor interactions: Implications for the function of G protein-coupled receptors
- S. Ferre, C. Quiroz, A.S. Woods, R. Cunha, P. Popoli, F. Ciruela, C. Lluis, R. Franco, K. Azdad, and S.N. Schiffmann An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors Curr. Pharm. Des. 14 2008 1468 1474
- (2008) Curr. Pharm. Des. , vol.14 , pp. 1468-1474
- Ferre, S.¹ Quiroz, C.² Woods, A.S.³ Cunha, R.⁴ Popoli, P.⁵ Ciruela, F.⁶ Lluis, C.⁷ Franco, R.⁸ Azdad, K.⁹ Schiffmann, S.N.¹⁰

6
- 0032497504
- Parkinson's disease. First of two parts
- A.E. Lang, and A.M. Lozano Parkinson's disease. First of two parts N. Engl. J. Med. 339 1998 1044 1053
- (1998) N. Engl. J. Med. , vol.339 , pp. 1044-1053
- Lang, A.E.¹ Lozano, A.M.²

7
- 0036827811
- Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes
- M.J. Millan, L. Maiofiss, D. Cussac, V. Audinot, J.A. Boutin, and A. Newman-Tancredi Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes J. Pharmacol. Exp. Ther. 303 2002 791 804
- (2002) J. Pharmacol. Exp. Ther. , vol.303 , pp. 791-804
- Millan, M.J.¹ Maiofiss, L.² Cussac, D.³ Audinot, V.⁴ Boutin, J.A.⁵ Newman-Tancredi, A.⁶

8
- 70349327971
- Adenosine A2A receptors and Parkinson's disease
- M. Morelli, A.R. Carta, and P. Jenner Adenosine A2A receptors and Parkinson's disease Handb. Exp. Pharmacol. 193 2009 589 615
- (2009) Handb. Exp. Pharmacol. , vol.193 , pp. 589-615
- Morelli, M.¹ Carta, A.R.² Jenner, P.³

9
- 59449110327
- The in vitro receptor profile of rotigotine: A new agent for the treatment of Parkinson's disease
- D. Scheller, C. Ullmer, R. Berkels, M. Gwarek, and H. Lubbert The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease Naunyn Schmiedebergs Arch. Pharmacol. 379 2009 73 86
- (2009) Naunyn Schmiedebergs Arch. Pharmacol. , vol.379 , pp. 73-86
- Scheller, D.¹ Ullmer, C.² Berkels, R.³ Gwarek, M.⁴ Lubbert, H.⁵

10
- 33748521261
- A simple and powerful flow cytometric method for the simultaneous determination of multiple parameters at G protein-coupled receptor subtypes
- E. Schneider, M. Mayer, R. Ziemek, L. Li, C. Hutzler, G. Bernhardt, and A. Buschauer A simple and powerful flow cytometric method for the simultaneous determination of multiple parameters at G protein-coupled receptor subtypes Chembiochem 7 2006 1400 1409
- (2006) Chembiochem , vol.7 , pp. 1400-1409
- Schneider, E.¹ Mayer, M.² Ziemek, R.³ Li, L.⁴ Hutzler, C.⁵ Bernhardt, G.⁶ Buschauer, A.⁷

11
- 33750171348
- Targeting adenosine A2A receptors in Parkinson's disease
- M.A. Schwarzschild, L. Agnati, K. Fuxe, J.F. Chen, and M. Morelli Targeting adenosine A2A receptors in Parkinson's disease Trends Neurosci. 29 2006 647 654
- (2006) Trends Neurosci. , vol.29 , pp. 647-654
- Schwarzschild, M.A.¹ Agnati, L.² Fuxe, K.³ Chen, J.F.⁴ Morelli, M.⁵

12
- 14544288232
- Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease
- K. Xu, E. Bastia, and M. Schwarzschild Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease Pharmacol. Ther. 105 2005 267 310
- (2005) Pharmacol. Ther. , vol.105 , pp. 267-310
- Xu, K.¹ Bastia, E.² Schwarzschild, M.³

13
- 79551492624
- FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors
- N. Ziegler, J. Batz, U. Zabel, M.J. Lohse, and C. Hoffmann FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors Bioorg. Med. Chem. 19 2011 1048 1054
- (2011) Bioorg. Med. Chem. , vol.19 , pp. 1048-1054
- Ziegler, N.¹ Batz, J.² Zabel, U.³ Lohse, M.J.⁴ Hoffmann, C.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.